Tolvaptan

Technical Data Of Tolvaptan

Application: Tolvaptan also known as OPC-41061, is a selective, competitive vasopressin receptor 2 antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH). Tolvaptan was approved by the U.S. Food and Drug Administration (FDA) on May 19, 2009.Tolvaptan was also in fast-track clinical trials for polycystic kidney disease